BMJ 2007;334:91-94 (13 January), doi:10.1136/bmj.39038.614317.AE
Practice
Cases in primary care laboratory medicine
Cases in primary care laboratory medicine: testing pitfalls and summary of guidance on sex hormone testing
W Stuart A Smellie, consultant
1 Clinical Laboratory, General Hospital, Bishop Auckland DL14 6AD
Correspondence to: W S A Smellie info@smellie.com
Sex hormone testing in women is difficult to interpret, and to produce valid conclusions tests must be timed correctly and follow a rational sequential testing strategy
| The first 150 words of the full text of this article appear below. |
Introduction
Laboratories see large differences in the use
of tests to investigate subfertility. The use and interpretation
of tests for the female sex hormones can be problematic; although
population reference data exist, values change markedly within
and between the different phases of the menstrual cycle, and
values outside of quoted reference ranges often provide very
limited information and can be misleading. This is particularly
true for women with cycles that are irregular or atypical in
length. Good examples of this can be seen in both menopause
and subfertility.
Summary points
- Hormone testing has very limited use in diagnosing the menopause
- Monitoring patients on hormone replacement therapy relies on clinical response in most situations
- Early investigation of subfertility is recommended only in specific groups of patients
- A detailed menstrual history is essential to interpret gonadotrophin results
- A luteal progesterone concentration above 20-30 nmol/l seven days before onset of menses effectively excludes endocrine related subfertility; . . . [Full text of this article]
| |
Case 1
Case 2
Discussion
Case 1Case 2Box 1: Who should be investigated for subfertility testing?
Questions and answers: learning points
Box 2: Recommended initial tests for investigation of subfertility in men and womenWhat tests should be used to investigate subfertility in men?What tests should be used to investigate subfertility in women?Box 3: Investigation of secondary amenorrhoeaWhen should secondary amenorrhoea be investigated?What tests should be used to investigate secondary amenorrhoea?What are the sources of evidence?Useful websites

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related Article
-
Testing pitfalls and summary of guidance in lipid management
- W Stuart A Smellie
BMJ 2006 333: 83-86.
[Extract]
[Full Text]
[PDF]